XML 66 R16.htm IDEA: XBRL DOCUMENT v3.20.1
Derivative Financial Instruments
3 Months Ended
Mar. 31, 2020
Derivative Instruments And Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments

6.

Derivative Financial Instruments

The Company may use derivative financial instruments, including interest rate swaps, caps, options, floors, and other interest rate derivative contracts, to hedge all or a portion of the interest rate risk associated with its borrowings. The principal objective of such arrangements is to minimize the risks and/or costs associated with the Company’s operating and financial structure as well as to hedge specific anticipated transactions. The Company does not intend to utilize derivatives for speculative or other purposes other than interest rate risk management. The use of derivative financial instruments carries certain risks, including the risk that the counterparties to these contractual arrangements are not able to perform under the agreements. To mitigate this risk, the Company only enters into derivative financial instruments with counterparties with high credit ratings and with major financial institutions with which the Company and its affiliates may also have other financial relationships. The Company does not anticipate that any of the counterparties will fail to meet their obligations.

The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount.

The following table summarizes the terms and fair values of the Company's derivative financial instruments, as well as their classification on the Consolidated Balance Sheets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair Value

 

(in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets (Liabilities) (1)

 

Effective

Date

 

Maturity

Date

 

Notional

Amount

 

 

Counterparty Pays

Variable Rate of

 

Regency Pays

Fixed Rate of

 

 

March 31, 2020

 

 

December 31, 2019

 

8/1/16

 

1/5/22

 

 

265,000

 

 

1 Month LIBOR with Floor

 

1.053%

 

 

$

(3,192

)

 

 

2,674

 

4/7/16

 

4/1/23

 

 

19,678

 

 

1 Month LIBOR

 

1.303%

 

 

 

(569

)

 

 

148

 

12/1/16

 

11/1/23

 

 

32,809

 

 

1 Month LIBOR

 

1.490%

 

 

 

(1,311

)

 

 

84

 

9/17/19

 

3/17/25

 

 

24,000

 

 

1 Month LIBOR

 

1.542%

 

 

 

(1,319

)

 

 

81

 

6/2/17

 

6/2/27

 

 

37,022

 

 

1 Month LIBOR with Floor

 

2.366%

 

 

 

(4,029

)

 

 

(1,515

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

(10,420

)

 

 

1,472

 

 

(1)

Derivatives in an asset position are included within Other assets in the accompanying Consolidated Balance Sheets, while those in a liability position are included within Accounts payable and other liabilities.

These derivative financial instruments are all interest rate swaps, which are designated and qualify as cash flow hedges. The Company does not use derivatives for trading or speculative purposes and, as of March 31, 2020, does not have any derivatives that are not designated as hedges.

The changes in the fair value of derivatives designated and qualifying as cash flow hedges is recorded in Accumulated Other Comprehensive Loss (“AOCI”) and subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings.

The following table represents the effect of the derivative financial instruments on the accompanying consolidated financial statements:

 

Location and Amount of Gain (Loss) Recognized in OCI on Derivative

 

 

Location and Amount of Gain (Loss) Reclassified from AOCI into (Loss) Income

 

 

Total amounts presented in the Consolidated Statements of Operations in which the effects of cash flow hedges are recorded

 

 

 

Three months ended

March 31,

 

 

 

 

Three months ended

March 31,

 

 

 

 

Three months ended

March 31,

 

(in thousands)

 

2020

 

 

2019

 

 

 

 

2020

 

 

2019

 

 

 

 

2020

 

 

2019

 

Interest rate swaps

 

$

(16,079

)

 

 

(5,489

)

 

Interest expense

 

$

1,425

 

 

 

(176

)

 

Interest expense, net

 

$

37,436

 

 

 

37,752

 

 

As of March 31, 2020, the Company expects approximately $7.4 million of net deferred losses on derivative instruments in AOCI, including the Company's share from its Investments in real estate partnerships, to be reclassified into earnings during the next 12 months. Included in the reclassification is $2.8 million related to previously settled swaps on the Company's ten and thirty year fixed rate unsecured debt.